<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Case report of a 39-year-old woman treated by <z:chebi fb="1" ids="4315">Danazol</z:chebi> for a paroxystic nocturnal <z:hpo ids='HP_0003641'>hemoglobinuria</z:hpo> who developed benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> and sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Bilateral <z:e sem="disease" ids="C0030353" disease_type="Disease or Syndrome" abbrv="">papilloedema</z:e> cleared 4 weeks after <z:chebi fb="1" ids="4315">Danazol</z:chebi> was stopped </plain></SENT>
<SENT sid="2" pm="."><plain>Twelve similar cases have already been reported in the literature </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="1" ids="4315">Danazol</z:chebi> should be added to the list of drugs potentially inducing pseudo-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cerebri </plain></SENT>
</text></document>